| Year |
Citation |
Score |
| 2024 |
Moreno-Rodríguez M, Martínez-Gardeazabal J, Bengoetxea de Tena I, Llorente-Ovejero A, Lombardero L, González de San Román E, Giménez-Llort L, Manuel I, Rodríguez-Puertas R. Cognitive improvement via cortical cannabinoid receptors and choline-containing lipids. British Journal of Pharmacology. PMID 39489624 DOI: 10.1111/bph.17381 |
0.791 |
|
| 2024 |
Martínez-Gardeazabal J, Pereira-Castelo G, Moreno-Rodríguez M, Llorente-Ovejero A, Fernández M, Fernández-Vega I, Manuel I, Rodríguez-Puertas R. Sphingosine 1-phosphate receptor subtype 1 (S1P) activity in the course of Alzheimer's disease. Neurobiology of Disease. 202: 106713. PMID 39448041 DOI: 10.1016/j.nbd.2024.106713 |
0.806 |
|
| 2024 |
Pereira-Castelo G, de Tena IB, Martínez-Gardeazabal J, Moreno-Rodríguez M, de San Román EG, Manuel I, Rodríguez-Puertas R. Neurolipid systems: A new target for the treatment of dementia. Basic & Clinical Pharmacology & Toxicology. PMID 39034736 DOI: 10.1111/bcpt.14059 |
0.733 |
|
| 2024 |
Moreno-Rodriguez M, Perez SE, Martinez-Gardeazabal J, Manuel I, Malek-Ahmadi M, Rodriguez-Puertas R, Mufson EJ. Frontal Cortex Lipid Alterations During the Onset of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 38578893 DOI: 10.3233/JAD-231485 |
0.785 |
|
| 2022 |
Martínez-Gardeazabal J, Moreno-Rodríguez M, de San Román EG, Abad B, Manuel I, Rodríguez-Puertas R. Mass Spectrometry for the Advancement of Lipid Analysis in Alzheimer's Research. Methods in Molecular Biology (Clifton, N.J.). 2561: 245-259. PMID 36399274 DOI: 10.1007/978-1-0716-2655-9_13 |
0.773 |
|
| 2022 |
Llorente-Ovejero A, Bengoetxea de Tena I, Martínez-Gardeazabal J, Moreno-Rodríguez M, Lombardero L, Manuel I, Rodríguez-Puertas R. Cannabinoid Receptors and Glial Response Following a Basal Forebrain Cholinergic Lesion. Acs Pharmacology & Translational Science. 5: 791-802. PMID 36110372 DOI: 10.1021/acsptsci.2c00069 |
0.758 |
|
| 2022 |
Bengoetxea de Tena I, Moreno-Rodríguez M, Llorente-Ovejero A, Monge-Benito S, Martínez-Gardeazabal J, Onandia-Hinchado I, Manuel I, Giménez-Llort L, Rodríguez-Puertas R. Handling and novel object recognition modulate fear response and endocannabinoid signaling in nucleus basalis magnocellularis. The European Journal of Neuroscience. 55: 1532-1546. PMID 35266590 DOI: 10.1111/ejn.15642 |
0.768 |
|
| 2021 |
González de San Román E, Llorente-Ovejero A, Martínez-Gardeazabal J, Moreno-Rodríguez M, Giménez-Llort L, Manuel I, Rodríguez-Puertas R. Modulation of Neurolipid Signaling and Specific Lipid Species in the Triple Transgenic Mouse Model of Alzheimer's Disease. International Journal of Molecular Sciences. 22. PMID 34830150 DOI: 10.3390/ijms222212256 |
0.808 |
|
| 2021 |
Llorente-Ovejero A, Martínez-Gardeazabal J, Moreno-Rodríguez M, Lombardero L, González de San Román E, Manuel I, Giralt MT, Rodríguez-Puertas R. Specific Phospholipid Modulation by Muscarinic Signaling in a Rat Lesion Model of Alzheimer's Disease. Acs Chemical Neuroscience. PMID 34037379 DOI: 10.1021/acschemneuro.1c00169 |
0.763 |
|
| 2021 |
Davis N, Mota BC, Stead L, Palmer EOC, Lombardero L, Rodríguez-Puertas R, de Paola V, Barnes SJ, Sastre M. Pharmacological ablation of astrocytes reduces Aβ degradation and synaptic connectivity in an ex vivo model of Alzheimer's disease. Journal of Neuroinflammation. 18: 73. PMID 33731156 DOI: 10.1186/s12974-021-02117-y |
0.78 |
|
| 2020 |
Rosell-Valle C, Pedraza C, Manuel I, Moreno-Rodríguez M, Rodríguez-Puertas R, Castilla-Ortega E, Caramés JM, Gómez Conde AI, Zambrana-Infantes E, Ortega-Pinazo J, Serrano-Castro PJ, Chun J, De Fonseca FR, Santín LJ, Estivill-Torrús G. Chronic central modulation of LPA/LPA receptors-signaling pathway in the mouse brain regulates cognition, emotion, and hippocampal neurogenesis. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110156. PMID 33152386 DOI: 10.1016/j.pnpbp.2020.110156 |
0.307 |
|
| 2020 |
Papon MA, Le Feuvre Y, Barreda-Gómez G, Favereaux A, Farrugia F, Bouali-Benazzouz R, Nagy F, Rodríguez-Puertas R, Landry M. Spinal Inhibition of GABAB Receptors by the Extracellular Matrix Protein Fibulin-2 in Neuropathic Rats. Frontiers in Cellular Neuroscience. 14: 214. PMID 32765223 DOI: 10.3389/Fncel.2020.00214 |
0.526 |
|
| 2019 |
Fernández RA, Garate J, Tolentino-Cortez T, Herraiz A, Lombardero L, Ducrocq F, Rodriguez-Puertas R, Trifilieff P, Astigarraga E, Barreda-Gómez G, Fernandez JA. Microarray and mass spectrometry-based Methodology for lipid profiling of tissues and cell cultures. Analytical Chemistry. PMID 31751120 DOI: 10.1021/Acs.Analchem.9B04529 |
0.762 |
|
| 2018 |
Manterola A, Bernal-Chico A, Cipriani R, Ruiz A, Pérez-Samartín A, Moreno-Rodríguez M, Hsu KL, Cravatt B, Brown JM, Rodríguez-Puertas R, Matute C, Mato S. Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis. Neuropharmacology. PMID 30171986 DOI: 10.1016/J.Neuropharm.2018.08.038 |
0.601 |
|
| 2018 |
Mato S, Pilar-Cuéllar F, Valdizán EM, González-Maeso J, Rodríguez-Puertas R, Meana J, Sallés J, Crespo-Facorro B, Pazos Á. Selective up-regulation of cannabinoid CB receptor coupling to Go-proteins in suicide victims with mood disorders. Biochemical Pharmacology. PMID 30099006 DOI: 10.1016/J.Bcp.2018.08.012 |
0.738 |
|
| 2018 |
Llorente-Ovejero A, Manuel I, Lombardero L, Giralt MT, Ledent C, Giménez-Llort L, Rodríguez-Puertas R. Endocannabinoid and Muscarinic Signaling Crosstalk in the 3xTg-AD Mouse Model of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 29865071 DOI: 10.3233/JAD-180137 |
0.811 |
|
| 2017 |
Llorente-Ovejero A, Manuel I, Giralt MT, Rodríguez-Puertas R. Increase of cortical endocannabinoid signaling in a rat model of basal forebrain cholinergic dysfunction. Neuroscience. PMID 28827178 DOI: 10.1016/j.neuroscience.2017.08.008 |
0.414 |
|
| 2017 |
Gónzalez de San Román E, Manuel I, Giralt MT, Ferrer I, Rodríguez-Puertas R. Imaging mass spectrometry (IMS) of cortical lipids from preclinical to severe stages of Alzheimer's disease. Biochimica Et Biophysica Acta. PMID 28527668 DOI: 10.1016/j.bbamem.2017.05.009 |
0.354 |
|
| 2016 |
Manuel I, Lombardero L, Laferla FM, Giménez-Llort L, Rodríguez-Puertas R. Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer's disease. Neuroscience. PMID 27223629 DOI: 10.1016/j.neuroscience.2016.05.012 |
0.812 |
|
| 2015 |
Barreda-Gómez G, Lombardero L, Giralt MT, Manuel I, Rodríguez-Puertas R. Effects of galanin subchronic treatment on memory and muscarinic receptors. Neuroscience. 293: 23-34. PMID 25732139 DOI: 10.1016/j.neuroscience.2015.02.039 |
0.791 |
|
| 2015 |
Manuel I, Barreda-Gómez G, González de San Román E, Veloso A, Fernández JA, Giralt MT, Rodríguez-Puertas R. Neurotransmitter receptor localization: from autoradiography to imaging mass spectrometry. Acs Chemical Neuroscience. 6: 362-73. PMID 25648777 DOI: 10.1021/cn500281t |
0.622 |
|
| 2015 |
Bernal-Chico A, Canedo M, Manterola A, Victoria Sánchez-Gómez M, Pérez-Samartín A, Rodríguez-Puertas R, Matute C, Mato S. Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo. Glia. 63: 163-76. PMID 25130621 DOI: 10.1002/Glia.22742 |
0.614 |
|
| 2014 |
Barreda-Gómez G, Giralt MT, Pazos A, Rodríguez-Puertas R. Galanin activated Gi/o-proteins in human and rat central nervous systems. Neuropeptides. 48: 295-304. PMID 25043784 DOI: 10.1016/j.npep.2014.06.002 |
0.588 |
|
| 2014 |
Manuel I, González de San Román E, Giralt MT, Ferrer I, Rodríguez-Puertas R. Type-1 cannabinoid receptor activity during Alzheimer's disease progression. Journal of Alzheimer's Disease : Jad. 42: 761-6. PMID 24946872 DOI: 10.3233/JAD-140492 |
0.387 |
|
| 2010 |
Morera-Herreras T, Ruiz-Ortega JA, Taupignon A, Baufreton J, Manuel I, Rodriguez-Puertas R, Ugedo L. Regulation of subthalamic neuron activity by endocannabinoids. Synapse (New York, N.Y.). 64: 682-98. PMID 20336631 DOI: 10.1002/syn.20778 |
0.712 |
|
| 1999 |
Rodríguez-Puertas R, Herrera-Marschitz M, Koistinaho J, Hökfelt T. Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine-lesioned rats. Neuroscience. 89: 781-97. PMID 10199613 DOI: 10.1016/S0306-4522(98)00370-4 |
0.516 |
|
| 1998 |
Herrera-Marschitz M, Goiny M, You ZB, Meana JJ, Engidawork E, Chen Y, Rodriguez-Puertas R, Broberger C, Andersson K, Terenius L, Hökfelt T, Ungerstedt U. Release of endogenous excitatory amino acids in the neostriatum of the rat under physiological and pharmacologically-induced conditions. Amino Acids. 14: 197-203. PMID 9871461 DOI: 10.1007/Bf01345262 |
0.676 |
|
| 1997 |
Herrera-Marschitz M, Goiny M, You ZB, Meana JJ, Pettersson E, Rodriguez-Puertas R, Xu ZQ, Terenius L, Hökfelt T, Ungerstedt U. On the release of glutamate and aspartate in the basal ganglia of the rat: interactions with monoamines and neuropeptides. Neuroscience and Biobehavioral Reviews. 21: 489-95. PMID 9195607 DOI: 10.1016/S0149-7634(96)00033-4 |
0.441 |
|
| 1996 |
Tomiyama M, Rodriguez-Puertas R, Cortés R, Christnacher A, Sommer B, Pazos A, Palacios JM, Mengod G. Differential regional distribution of AMPA receptor subunit messenger RNAs in the human spinal cord as visualized by in situ hybridization. Neuroscience. 75: 901-15. PMID 8951883 DOI: 10.1016/0306-4522(96)00321-1 |
0.618 |
|
| 1996 |
Pettersson E, Herrera-Marschitz M, Rodriguez-Puertas R, Xu ZQ, You ZB, Hughes J, Elde RP, Ungerstedt U, Hökfelt T. Evidence for aspartate-immunoreactive neurons in the neostriatum of the rat: modulation by the mesencephalic dopamine pathway via D1-subtype of receptor. Neuroscience. 74: 51-66. PMID 8843077 DOI: 10.1016/0306-4522(96)00124-8 |
0.459 |
|
| Show low-probability matches. |